Cerebrum DAO (NEURON) Crypto Coin Explained

Cerebrum DAO (NEURON) Crypto Coin Explained
10 Comments

NEURON Token Value Calculator

Current NEURON Token Info

Max Supply: 86 billion NEURON

Circulating Supply: 26.03 billion

Current Price: $0.0002906

Market Cap: $7.45 million

Your Investment

Projected Value Analysis

Enter your investment details and click "Calculate Potential Value" to see projected returns based on NEURON token growth forecasts.

When it comes to blockchain‑driven science funding, Cerebrum DAO is a decentralized autonomous organization focused on neuroscience research and neurodegenerative disease solutions that powers its ecosystem with the NEURON token. The project blends DeFi, NFTs and community governance to create a sustainable financing model for cutting‑edge brain research.

What is Cerebrum DAO?

Cerebrum DAO belongs to a new class of organisations called BioDAO. Unlike traditional charities, a BioDAO runs on public blockchain code, letting anyone with a wallet propose, vote on, and fund scientific projects. The core mission is to accelerate research on neurodegenerative diseases such as Alzheimer’s and Parkinson’s by removing the middle‑man of grant‑making and giving researchers direct access to capital.

NEURON Token Basics

The NEURON token serves two roles: governance and utility. Token holders vote on everything from which research proposals receive funding to how the treasury is allocated. On the utility side, NEURON grants early access to IP‑NFT sales, discounted brain‑health products, and eventually the first wave of approved therapeutics that emerge from the DAO’s portfolio.

Tokenomics at a Glance

Key numbers are deliberately tied to the human brain. The maximum supply is exactly 86billion tokens - roughly the number of neurons in an adult brain. As of October2025, 26.03billion tokens are circulating, representing about 30% of the total supply. The token trades around $0.0002906 USD, giving the project a market cap of $7.45million and a 24‑hour volume of $189k.

  • Max supply: 86billion NEURON
  • Circulating supply: 26.03billion
  • Current price (USD): $0.0002906
  • Market cap: $7.45million
  • 24‑hr volume: $189k

Governance and Utility Features

NEURON holders enjoy a suite of rights that go beyond voting:

  1. IP‑NFT Access: Participate in fractional sales of intellectual‑property NFTs created from funded research.
  2. IPT Purchase Rights: When an IP‑NFT is split into Intellectual Property Tokens (IPTs), NEURON holders get first‑come, first‑served buying privileges.
  3. Discounted Products: Early‑bird pricing on brain‑health supplements, diagnostics and wearables sourced by the DAO.
  4. Therapeutic Priority: Long‑term holders receive preferential, discounted access to approved drugs that originate from the DAO’s pipeline.
IP‑NFT and IPT Model Explained

IP‑NFT and IPT Model Explained

The DAO’s funding engine hinges on two novel asset classes:

Intellectual Property NFTs (IP‑NFTs) are minted when the DAO decides to back a research project. Each IP‑NFT encodes the project’s milestones, ownership rights and a future revenue‑share plan. Once the first milestone is met, the IP‑NFT can be fractionalized into Intellectual Property Tokens (IPTs). These tokens trade on open markets, letting investors fund a specific stage of a study without committing to the whole pipeline.

The DAO retains a controlling stake in every IPT batch, ensuring that the project stays aligned with the broader scientific mission while still providing liquidity to token holders.

Market Outlook and Price Predictions

Forecasts from three analytics platforms paint an optimistic medium‑term picture:

  • TradingBeasts: Average price near $0.0001369 by December2029, with a potential high of $0.0001451.
  • LiteFinance: Projects an annual rise of roughly 2.75%, ending 2029 at $0.0001421.
  • Wallet Investor: Sees a floor of $0.0001287 by 2029 and a possible peak of $0.000165 in 2031.

While these numbers are speculative, they suggest that NEURON could double or triple its current price if the DAO’s research pipeline yields tangible results.

Comparison with Other BioDAO Tokens

Key metrics of NEURON vs. two comparable BioDAO tokens
Token Total Supply Current Price (USD) Market Cap (USD) Primary Research Focus
NEURON 86billion 0.0002906 7.45M Neuro‑degeneration
GNY 100billion 0.000045 4.5M Genomics & AI
OCEAN 1.41billion 0.30 425M Data marketplaces for life‑science research

NEURON’s tokenomics are uniquely symbolic, and its governance model is tightly coupled to a single disease area, which can be a strength for investors seeking niche exposure.

Risk Factors and Considerations

  • Liquidity: With a 24‑hour volume under $200k, large trades can move the price noticeably.
  • Regulatory uncertainty: Tokenizing intellectual property for medical research may attract scrutiny from securities regulators.
  • Scientific risk: Research outcomes are inherently uncertain; a failed trial can diminish the token’s utility.
  • Governance concentration: If a few large wallets accumulate >50% of NEURON, decision‑making could become centralized.

How to Join Cerebrum DAO

  1. Set up a compatible wallet (e.g., MetaMask) and ensure it supports the ERC‑20 standard.
  2. Buy NEURON on a supported exchange (check the latest listing page for the most recent venues).
  3. Transfer the tokens to your personal wallet - never leave them on an exchange if you plan to vote.
  4. Visit the DAO’s governance portal, connect your wallet, and start reviewing proposals.
  5. Participate in IP‑NFT sales or IPT purchases when announced; these opportunities are posted in the DAO’s Discord and Telegram channels.

Staying active in community chats helps you spot upcoming research milestones and gives you a voice in how the treasury is deployed.

Frequently Asked Questions

Frequently Asked Questions

What makes NEURON different from regular utility tokens?

NEURON ties its supply to the estimated number of neurons in the human brain and grants holders direct influence over scientific research, IP‑NFT access, and future therapeutic discounts - benefits you don’t see in typical DeFi tokens.

Can I sell my NEURON tokens on any exchange?

NEURON is listed on a handful of midsize crypto exchanges. Always verify the trading pair and use a secure, non‑custodial wallet for voting and participating in DAO events.

How are research projects selected?

Project leads submit detailed proposals to the DAO’s portal. NEURON holders then vote on funding allocation. Proposals must include clear milestones, budgets, and ethical approvals.

What are IP‑NFTs and why should I care?

An IP‑NFT represents the ownership and future revenue rights of a funded research project. When fractionalized into IPTs, it lets investors buy a slice of that future upside while the DAO retains strategic control.

Will I ever get the actual drug if the research succeeds?

Long‑term NEURON holders receive discounted, priority access to any therapeutics that emerge from the DAO’s pipeline, subject to regulatory approval in their jurisdiction.

Is there a minimum holding period to enjoy the therapeutic discounts?

The DAO’s policy currently rewards wallets that have held NEURON for at least 12months, but the exact tiering may be updated through community votes.

Adarsh Menon
Adarsh Menon 4 Oct

NEURON? Just another hype token

Eva Lee
Eva Lee 4 Oct

The tokenomics model of NEURON leverages a capped supply tied to neurobiological estimates, which technically introduces a novel scarcity metric.
However, the governance framework still relies on a simple majority vote, raising concerns about vote‑splitting and quorum thresholds.
Liquidity provision on secondary markets is currently thin, so slippage may erode any arbitrage opportunities.
From a technical standpoint, the smart‑contract audit shows no glaring vulnerabilities, but the upgrade path remains opaque.
In practice, prospective holders should weigh the speculative upside against the operational risk of DAO‑centric decision making.

Promise Usoh
Promise Usoh 4 Oct

One might contemplate the ontological significance of tethering a digital asset to the approximate neuronal count of Homo sapiens.
Such a symbolic anchoring invites reflection on the convergence of epistemic ambition and monetary abstraction.
Yet the pragmatic mechanisms of voting power and token distribution remain subject to the same market dynamics as any other ERC‑20.
The proposal to allocate research funding through collective deliberation is philosophically appealing, though it presupposes a rational electorate.
Moreover, the recursive feedback loop-whereby token value may be influenced by research outcomes-poses an intriguing, albeit risky, incentive structure.
Ultimately, the success of this experiment will hinge upon the community's capacity to balance visionary goals with sober risk management.

Shaian Rawlins
Shaian Rawlins 4 Oct

I get the excitement around a token that promises a slice of future biotech breakthroughs.
What really matters is whether the DAO can consistently fund credible projects and not just chase hype.
The roadmap mentions IP‑NFTs, which could democratize ownership of intellectual property, but the legal framework is still fuzzy.
People should keep an eye on how the treasury is allocated; transparent reporting will be key to maintaining trust.
Also, the discount on eventual therapeutics is a nice perk, yet regulatory approval timelines can be decades long.
For anyone thinking short‑term profit, this is probably not the play, but for long‑term believers it could be rewarding.
Engage in the community channels, ask questions, and vote-participation is the real value‑add.
In short, treat NEURON as a high‑risk, high‑potential research accelerator rather than a meme coin.

Tyrone Tubero
Tyrone Tubero 4 Oct

The allure of NEURON lies in its veneer of scientific legitimacy.
But beneath the glossy whitepaper, the tokenomics are as thin as a hospital gown.
Investors should beware of the inevitable dilution once more IP‑NFTs are minted.

Bhagwat Sen
Bhagwat Sen 4 Oct

Hold up, you’re dismissing the whole IP‑NFT concept like it’s a gimmick?
The DAO actually lets token‑holders co‑own future patents, which is a paradigm shift in how we think about value creation.
Don’t let the “thin” treasury argument blind you to the upside of collective R&D ownership.

Cathy Ruff
Cathy Ruff 4 Oct

Looks like another pump‑and‑dump waiting to happen
Don’t fall for the “research” hype

mukesh chy
mukesh chy 4 Oct

Oh wow, you think it’s a pump‑and‑dump? That’s adorable.
Maybe if you actually read the governance docs you’d see it’s not just hype.

Marc Addington
Marc Addington 4 Oct

America’s best brains are behind this, so it’s obviously legit.
Anyone who doubts it is just anti‑innovation.

stephanie lauman
stephanie lauman 4 Oct

The surge in NEURON’s price coincides suspiciously with a coordinated social media push, suggesting manipulation by insider groups.
Given the token’s ties to cutting‑edge neuroscience, it’s plausible that secretive labs are funneling research data to sway voting outcomes.
The DAO’s voting anonymity could mask a concentration of power among a few undisclosed entities.
Furthermore, the proposed therapeutic discounts might be a front to secure preferential market access for certain pharma partners.
Until transparent audits of these relationships are published, skepticism remains warranted.

10 Comments